E
6.10
-0.27 (-4.24%)
| 前收盘价格 | 6.37 |
| 收盘价格 | 6.01 |
| 成交量 | 241,807 |
| 平均成交量 (3个月) | 280,230 |
| 市值 | 129,285,224 |
| 价格/销量 (P/S) | 1.97 |
| 股市价格/股市净资产 (P/B) | 1.04 |
| 52周波幅 | |
| 利润日期 | 5 Feb 2025 - 10 Feb 2025 |
| 营业毛利率 | -160.27% |
| 营业利益率 (TTM) | -134.58% |
| 稀释每股收益 (EPS TTM) | -5.48 |
| 季度收入增长率 (YOY) | -4.90% |
| 总债务/股东权益 (D/E MRQ) | 151.88% |
| 流动比率 (MRQ) | 4.92 |
| 营业现金流 (OCF TTM) | -89.97 M |
| 杠杆自由现金流 (LFCF TTM) | -63.27 M |
| 资产报酬率 (ROA TTM) | -17.18% |
| 股东权益报酬率 (ROE TTM) | -59.64% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | Enanta Pharmaceuticals, Inc. | 看跌 | 看跌 |
AIStockmoo 评分
0.9
| 分析师共识 | 3.0 |
| 内部交易活动 | NA |
| 价格波动 | 3.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -2.5 |
| 平均 | 0.88 |
|
Enanta Pharmaceuticals Inc is an American biotechnology company focused on the research and development of molecule drugs to cure viral infections and liver diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 6.09% |
| 机构持股比例 | 100.66% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Krensavage Asset Management, Llc | 30 Sep 2024 | 1,498,074 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 21.00 (JMP Securities, 244.26%) | 购买 |
| 中 | 20.00 (227.87%) | |
| 低 | 18.00 (HC Wainwright & Co., 195.08%) | 购买 |
| 平均值 | 19.67 (222.46%) | |
| 总计 | 3 购买 | |
| 平均价格@调整类型 | 7.74 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| HC Wainwright & Co. | 24 Dec 2024 | 18.00 (195.08%) | 购买 | 6.10 |
| 10 Oct 2024 | 27.00 (342.62%) | 购买 | 10.63 | |
| Baird | 26 Nov 2024 | 20.00 (227.87%) | 购买 | 8.56 |
| JMP Securities | 26 Nov 2024 | 21.00 (244.26%) | 购买 | 8.56 |
| 09 Oct 2024 | 22.00 (260.66%) | 购买 | 10.71 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合